An increase in hospital-acquired infections, supply chain challenges, cost containment, and a backlog of some endoscopic procedures have been catalysts for migrating from reusable to single-use endoscopies.
The global disposable endoscope market size is predicted to reach $2.7 billion by 2025 – an astoundingly large number! Though not all-inclusive, this disposable endoscopic market incorporates bronchoscopy, GI endoscopy, ENT endoscopy, urologic, and arthroscopy. An increase in hospital-acquired infections, supply chain challenges, cost containment, and the backlog of some endoscopic procedures have contributed to migrating from reusable to single-use endoscopies.
The cost of a reusable endoscopy ranges from $1,400 to $1,900 for each procedure, which does not include the cost for disinfection, repairs, and reprocessing. Reprocessing costs are particularly high, especially in the climate of COVID, in terms of double disinfection, labor, training, education, disinfection supplies, etc. In general, hospital-acquired infections arise in 1 to 1.2 percent of the procedures performed, which can be quite impactful to organizations financially and damage their overall reputation. Essentially, single-use endoscopes improve workflow and efficiency by streamlining operations.
With the onset of COVID, single-use endoscopies have played a significant role in improving efficiencies, and in some cases, saving money. Disinfecting reusable endoscopes can take up to two hours; however, achieving a guarantee of 100 percent clean is close to impossible. With the backlog of non-emergent care procedures, the risk of infection increases if the ability for disinfection is delayed.
Older technologies that require close contact with a patient, such as an ENT scope, place the doctor and patient in close proximity. Video technology allows an increased distance from clinician to patient. When non-emergent procedures came to a halt during COVID, reusable equipment began collecting dust while remaining on the balance sheet. Single-use endoscopes are considered supplies and do not depreciate, creating create predictable margins.
Effective July 1, 2020, HCPCS code C1748 for Endoscope, single-use (i.e., disposable), upper GI, imaging/illumination device (insertable) was approved as a transitional pass-through item through June 30, 2023. Transitional pass-through status is intended to encourage the use of newly FDA-approved medical devices, drugs, and biologics across all fields of medicine and to boost Medicare patients’ access to these innovative therapies by temporarily paying more than established facility fees. The Transitional Pass-Through (TPT) payment formula is derived from using the charge for the procedure performed multiplied by the cost-to-charge ratio. This allows payment for the TPT, as well as payment for the procedure performed.
For billing purposes, the CPT® procedure code is reported for the procedure performed. The transitional pass-through code is reported under sterile supplies (Revenue Code 272 or Revenue Code 278) for medical or surgical implants. Please note that not all third-party payors will reimburse for single-use endoscopes. It is advised to review third-party contract language to determine specific reimbursement coverage. It is anticipated that this market will only expand due to the momentum and interest generated by single-use endoscopies.
The following CPT codes are reportable with HCPCS Code C1748, effective July 1, 2020 to June 30, 2023:
Programming Note: Listen to Susan Gatehouse report this story live today during Talk Ten Tuesdays, 10 Eastern.
If you have been listening to the discussions on Monitor Monday and Talk Ten Tuesday about the use of the new HCPCS code G2211, you
Many of you may be aware last year the Centers for Medicare & Medicaid Services (CMS) added HCPCS code G2211 that physicians can use in
Please log in to your account to comment on this article.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.
During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.
Learn how to navigate the proposed elimination of the Inpatient-Only list. Gain strategies to assess admission status, avoid denials, protect compliance, and address impacts across Medicare and non-Medicare payors. Essential insights for hospitals.
RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.
Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more
Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
